Literature DB >> 24895239

Combining MRI and muscle biopsy improves diagnostic accuracy in subacute-onset idiopathic inflammatory myopathy.

Janneke Van De Vlekkert1, Mario Maas, Jessica E Hoogendijk, Marianne De Visser, Ivo N Van Schaik.   

Abstract

INTRODUCTION: In 10-20% of patients with subacute-onset idiopathic inflammatory myopathy (IIM), muscle biopsy is normal or shows nonspecific findings. MRI can be used as a triage test before muscle biopsy and as an add-on test if the biopsy is nondiagnostic.
METHODS: MRI scans of skeletal muscles and muscle biopsies were evaluated prospectively in 48 patients suspected to have IIM. The interpretations of MRI and muscle biopsy were compared with the definite diagnosis (based on European Neuromuscular Centre criteria and response to corticosteroids).
RESULTS: The false negative rate (FNR) of all muscle biopsies was 0.23. Biopsies of a muscle showing hyperintensity on MRI (as triage test) had an FNR of 0.19. The result of MRI as an add-on test in patients with a nondiagnostic muscle biopsy decreased the FNR from 0.23 to 0.06.
CONCLUSIONS: We recommend both MRI and muscle biopsy in patients suspected of having IIM.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  dermatomyositis; idiopathic inflammatory myopathy; muscle MRI; muscle biopsy; myositis

Mesh:

Year:  2015        PMID: 24895239     DOI: 10.1002/mus.24307

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  20 in total

Review 1.  Diagnostic Imaging of Inflammatory Myopathies: New Concepts and a Radiological Approach.

Authors:  Júlio Brandão Guimarães; Marcelo A Nico; Alípio G Omond; Laís Uyeda Aivazoglou; Rafael Baches Jorge; Edmar Zanoteli; Artur R C Fernandes
Journal:  Curr Rheumatol Rep       Date:  2019-02-14       Impact factor: 4.592

Review 2.  Autoimmune Myopathies.

Authors:  Andrew L Mammen
Journal:  Continuum (Minneap Minn)       Date:  2016-12

Review 3.  [Myositides: What is the current situation?].

Authors:  K M Rösler; O Scheidegger
Journal:  Z Rheumatol       Date:  2015-08       Impact factor: 1.372

Review 4.  Update on muscle disease.

Authors:  J Witherick; S Brady
Journal:  J Neurol       Date:  2018-04-18       Impact factor: 4.849

5.  Comparison of the 2017 EULAR/ACR criteria with Bohan and Peter criteria for the classification of idiopathic inflammatory myopathies.

Authors:  Benzeeta Pinto; Ramya Janardana; Raghunanadan Nadig; Anita Mahadevan; Anusha S Bhatt; John Michael Raj; Vineeta Shobha
Journal:  Clin Rheumatol       Date:  2019-03-22       Impact factor: 2.980

6.  Clinical value of a [18F]-FDG PET-CT muscle-to-muscle SUV ratio for the diagnosis of active dermatomyositis.

Authors:  Nihal Martis; Philippe Viau; Thierry Zenone; Fanny Andry; Aurélie Grados; Mikael Ebbo; Emeline Castela; Benoit Brihaye; Eric Denis; Stéphane Liguori; Alexandra Audemard; Yoland Schoindre; Anne-Sophie Morin; Benjamin Terrier; Laurent Marcq; Nicolas Mounier; Olivier Lidove; Jean-Philippe Chaborel; Denis Quinsat
Journal:  Eur Radiol       Date:  2019-06-27       Impact factor: 5.315

Review 7.  Role of MRI in diagnosis and management of idiopathic inflammatory myopathies.

Authors:  Britta Maurer; Ulrich A Walker
Journal:  Curr Rheumatol Rep       Date:  2015-11       Impact factor: 4.592

8.  Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity.

Authors:  Iago Pinal-Fernandez; Maria Casal-Dominguez; John A Carrino; Arash H Lahouti; Pari Basharat; Jemima Albayda; Julie J Paik; Shivani Ahlawat; Sonye K Danoff; Thomas E Lloyd; Andrew L Mammen; Lisa Christopher-Stine
Journal:  Ann Rheum Dis       Date:  2016-09-20       Impact factor: 19.103

Review 9.  Immune-Mediated Necrotizing Myopathy.

Authors:  Iago Pinal-Fernandez; Maria Casal-Dominguez; Andrew L Mammen
Journal:  Curr Rheumatol Rep       Date:  2018-03-26       Impact factor: 4.592

Review 10.  PET Scan: Nuclear Medicine Imaging in Myositis.

Authors:  Albert Selva-O'Callaghan; Albert Gil-Vila; Marc Simó-Perdigó; Ernesto Trallero-Araguás; Marcelo Alvarado-Cárdenas; Iago Pinal-Fernandez
Journal:  Curr Rheumatol Rep       Date:  2019-11-21       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.